LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-22. Anything still debated is marked as such rather than presented as settled.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
It is the usual line used in the United States to determine treatment of acetaminophen overdose after the publication of the NAC study in 1981. With early NAC and supportive therapy, the majority of patients recover with no adverse effects. Of patients that progress to acute liver failure, 65% of patients will recover; the remainder will either require liver transplantation or die.
For given RTD, there is an upper limit on the amount of mixing that can occur, called the maximum mixedness, and this determines the achievable yield. A continuous stirred-tank reactor can be anywhere in the spectrum between completely segregated and perfect mixing. The RTD of chemical reactors can be obtained by CFD simulations. The very same procedure that is performed in experiments can be followed. A pulse of inert tracer particles (during a very short time) is injected into the reactor. The linear motion of tracer particles is governed by Newton's second law of motion and a one-way coupling is stablished between fluid and tracers. In one-way coupling, fluid affects tracer motion by drag force while tracer does not affect fluid. The size and density of tracers are chosen so small that the time constant of tracers becomes very small. In this way, tracer particles exactly follow the same path as the fluid does.
=== BLOSUM === BLOSUM80: more related proteins BLOSUM62: midrange BLOSUM45: distantly related proteins The BLOSUM62 matrix with the amino acids in the table grouped according to the chemistry of the side chain, as in (a). Each value in the matrix is calculated by dividing the frequency of occurrence of the amino acid pair in the BLOCKS database, clustered at the 62% level, divided by the probability that the same two amino acids might align by chance. The ratio is then converted to a logarithm and expressed as a log odds score, as for PAM. BLOSUM matrices are usually scaled in half-bit units. A score of zero indicates that the frequency with which a given two amino acids were found aligned in the database was as expected by chance, while a positive score indicates that the alignment was found more often than by chance, and negative score indicates that the alignment was found less often than by chance.
== See also == Adhesion – the attraction of molecules or compounds for other molecules of a different kind Specific heat capacity – the amount of heat needed to raise the temperature of one gram of a substance by one degree Celsius Heat of vaporization – the amount of energy needed to change one gram of a liquid substance to a gas at constant temperature Zwitterion – a molecule composed of individual functional groups which are ions, of which the most prominent examples are the amino acids Chemical polarity – a neutral, or uncharged molecule or its chemical groups having an electric dipole moment, with a negatively charged end and a positively charged end
=== Pregnancy === It is possible that relaxin in the placenta could be a contributing factor to inducing labour in humans and therefore serum relaxin levels during pregnancy have been linked to premature birth.
Sources: en.wikipedia.org
In the face of energetic German attempts to Nazify the international body, Jung resigned from its presidency in 1939, the year the Second World War started. Scholar Yosef Hayim Yerushalmi believed that Jung's antisemitism may have contributed to the schism between Freud and his circle of psychoanalysts, who were predominantly Jews. Jung is known to have possessed an interest in the Jewish mystic tradition of Kabbalah. and his interest in European mythology and folk psychology was shared by the Nazis. Richard Noll describes Jung's own reaction to this connection:
The stramenopiles, also known as heterokontophytes, are a very large and diverse group of eukaryotes. It inlcludes Ochrophyta—which includes diatoms, brown algae (seaweeds), and golden algae (chrysophytes)— and Xanthophyceae (also called yellow-green algae). Heterokont chloroplasts are very similar to haptophyte chloroplasts. They have a pyrenoid, triplet thylakoids, and, with some exceptions, four layer plastidic envelope with the outermost membrane connected to the endoplasmic reticulum. Like haptophytes, stramenopiles store sugar in chrysolaminarin granules in the cytoplasm. Stramenopile chloroplasts contain chlorophyll a and, with a few exceptions, chlorophyll c. They also have carotenoids which give them their many colors.
=== Competing narratives === In the years immediately following the revolution, narratives applied both by Romanians and the international audience competed for an interpretation of the events of 1989. Within Romania, myths interpreting it as "false" or "stolen" by the FSN correlated to one's level of disagreement with the political organization, while those painting the events as a pure, "spontaneous revolution" largely aligned with support for the FSN. In addition, the FSN itself attempted to construct its own narrative of the revolution, with its leaders placed abruptly at the center by popular will. This interpretation was largely challenged by FSN opponents.
In exclusive arrangements, the distributor is expected to work closely with the manufacturer and add value to the product through service level, after sales care or client support services. Another definition of exclusive arrangement is an agreement between a supplier and a retailer granting the retailer exclusive rights within a specific geographic area to carry the supplier's product. Summary of strategic approaches to distribution
Sources: en.wikipedia.org
In addition to reworking Xen from scratch, as the team members got closer to release, they recognized they saw the game more as an entry for new players into the Half-Life series, and worked to introduce designs and features that would be more appropriate a decade since Half-Life's release. They made combat more interesting by improving the enemy's artificial intelligence while creating combat areas with more cover and options for the player. Because of their expansion of Xen, they also wanted to make sure players were not slowed down in the earlier parts of the game, and made redesigns in some of these levels. The release of Xen in the early access version of Black Mesa had been pushed off a few times; initially planned for a December 2017 release, a beta version of a segment of the remade Xen was released in June 2019 for stress-testing by players The full beta was released on December 6, 2019. Additional Xen levels were added over time, and by December 24, 2019, the full Xen chapter was released as part of the game's early access. The finished Black Mesa was released for Windows on March 6, 2020. By chance, this release was about two weeks before Valve's official return to the Half-Life universe after 13 years with the virtual reality game Half-Life: Alyx. Black Mesa project lead Adam Engels said this was not intentional as they had planned to have Black Mesa out earlier, but the attention to Alyx had helped to boost interest in Black Mesa.
=== Biology and medicine === Abductor digiti minimi muscle of hand Adrenomedullin, a vasodilator peptide hormone Acinar-to-ductal metaplasia, a condition affecting pancreatic cells (see Acinar cell § Acinar-to-ductal metaplasia)
Powstanie Wielkopolskie, [in:] J.Pajewski, Odbudowa państwa polskiego 1914–1918, Warszawa 1985, Janusz Pajewski, Znaczenia Powstania Wielkopolskiego dla odbudowy Państwa Polskiego w 1918 r., Zeszyty Naukowe UAM, Historia 1970, t.10 S. Rybka, Zerwane pęta. Wspomnienia z dni rewolucji niemieckiej i powstania polskiego 1918-1919, Poznań 1919 A. Rzepecki, Powstanie grudniowe w Wielkopolsce. 27 XII 1918, Poznań 1919 Z. Wieliczka, Wielkopolska w Prusy w dobie powstania 1918/1919, Poznań 1932 Z. Wroniak, Paderewski w Poznaniu, Kronika Miasta Poznania 1959, nr 4 H. Zieliński, Rola powstania wielkopolskiego oraz powstań śląskich w walce o zjednoczenie ziem zachodnich z Polską; (1918–1921), [in:] Droga przez Półwiecze. Dietrich Vogt: Der großpolnische Aufstand 1918/1919: Bericht, Erinnerungen, Dokumente. Marburg 1980 (J.-G.-Herder-Institut) ISBN 3-87969-147-9 Richard Blanke, Orphans of Versailles. The Germans in Western Poland 1918–1939, Lexington, KY., 1993 (presents somehow pro-German vision of the events)
DCPIP (blue) + H+ → DCPIPH (pink) DCPIPH (pink) + vitamin C → DCPIPH2 (colorless) In this titration, when all the ascorbic acid in the solution has been used up, there will not be any electrons available to reduce the DCPIPH and the solution remains pink due to the DCPIPH. The end point is a pink color that persists for 10 seconds or more, if there is not enough ascorbic acid to reduce all of the DCPIPH. Pharmacological experiments suggest that DCPIP may serve as a pro-oxidant chemotherapeutic targeting human cancer cells in an animal model of human melanoma; DCPIP-induced cancer cell death occurs by depletion of intracellular glutathione and upregulation of oxidative stress.
Molecular dimers are often formed by the reaction of two identical compounds e.g.: 2A → A−A. In this example, monomer "A" is said to dimerize to give the dimer "A−A". Dicyclopentadiene is an asymmetrical dimer of two cyclopentadiene molecules that have reacted in a Diels-Alder reaction to give the product. Upon heating, it "cracks" (undergoes a retro-Diels-Alder reaction) to give identical monomers:
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.